Herrinton Lisa J, Shorstein Neal H, Paschal John F, Liu Liyan, Contreras Richard, Winthrop Kevin L, Chang William J, Melles Ronald B, Fong Donald S
Division of Research, Kaiser Permanente Northern California, Oakland, California.
Departments of Ophthalmology and Quality, Kaiser Permanente, Walnut Creek, California.
Ophthalmology. 2016 Feb;123(2):287-294. doi: 10.1016/j.ophtha.2015.08.039. Epub 2015 Oct 14.
Intracameral injection is an effective method for preventing infection, but no controlled study has been published in the United States.
We conducted an observational, longitudinal cohort study to examine the effect of topical and injected antibiotics on risk of endophthalmitis.
We identified 315 246 eligible cataract procedures in 204 515 members of Kaiser Permanente, California, 2005-2012.
The study used information from the membership, medical, pharmacy, and surgical records from the electronic health record.
The adjusted odds ratio (OR) and 95% confidence interval (CI) for the association of antibiotic prophylaxis (route and agent) with risk of endophthalmitis was estimated using logistic regression analysis.
We confirmed 215 cases of endophthalmitis (0.07% or 0.7/1000). Posterior capsular rupture was associated with a 3.68-fold increased risk of endophthalmitis (CI, 1.89-7.20). Intracameral antibiotic was more effective than topical agent alone (OR, 0.58; CI, 0.38-0.91). Combining topical gatifloxacin or ofloxacin with intracameral agent was not more effective than using an intracameral agent alone (compared with intracameral only: intracameral plus topical, OR, 1.63; CI, 0.48-5.47). Compared with topical gatifloxacin, prophylaxis using topical aminoglycoside was ineffective (OR, 1.97; CI, 1.17-3.31).
Surgical complication remains a key risk factor for endophthalmitis. Intracameral antibiotic was more effective for preventing post-cataract extraction endophthalmitis than topical antibiotic alone. Topical antibiotic was not shown to add to the effectiveness of an intracameral regimen.
前房内注射是预防感染的一种有效方法,但在美国尚未发表对照研究。
我们进行了一项观察性纵向队列研究,以检查局部和注射用抗生素对眼内炎风险的影响。
我们在2005年至2012年期间,从加利福尼亚州凯撒医疗集团的204515名成员中确定了315246例符合条件的白内障手术。
该研究使用了来自电子健康记录中的会员、医疗、药房和手术记录信息。
使用逻辑回归分析估计抗生素预防(途径和药物)与眼内炎风险之间关联的调整比值比(OR)和95%置信区间(CI)。
我们确认了215例眼内炎病例(0.07%或0.7/1000)。后囊破裂与眼内炎风险增加3.68倍相关(CI,1.89 - 7.20)。前房内抗生素比单独使用局部药物更有效(OR,0.58;CI,0.38 - 0.91)。将局部加替沙星或氧氟沙星与前房内药物联合使用并不比单独使用前房内药物更有效(与仅前房内用药相比:前房内加局部用药,OR,1.63;CI,0.48 - 5.47)。与局部加替沙星相比,使用局部氨基糖苷类药物进行预防无效(OR,1.97;CI,1.17 - 3.31)。
手术并发症仍然是眼内炎的关键危险因素。前房内抗生素在预防白内障摘除术后眼内炎方面比单独使用局部抗生素更有效。未显示局部抗生素能增加前房内用药方案的有效性。